HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (11)
2023
-
Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial
Heart rhythm, Vol. 20, Núm. 6, pp. 822-830
2021
-
Tenorio syndrome: Description of 14 novel cases and review of the clinical and molecular features
Clinical Genetics, Vol. 100, Núm. 4, pp. 405-411
2020
-
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2019
-
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744
2018
2016
-
Delphi consensus on attention deficit hyperactivity disorder (ADHD): Evaluation by a panel of experts
Actas Espanolas de Psiquiatria, Vol. 44, Núm. 6, pp. 231-243
-
Intramyocardial Dissecting Hematoma: Cardiac Trauma and Ischemic Heart Disease: Multimodality Imaging Techniques
Echocardiography, Vol. 33, Núm. 8, pp. 1262-1264
2006
-
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: Efficacy and correlation with HER2 extracellular domain
Clinical and Translational Oncology, Vol. 8, Núm. 12, pp. 896-902
2001
-
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial
Journal of the National Cancer Institute, Vol. 93, Núm. 1, pp. 31-38